| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/10/2011 | CA2411056C Pharmaceutical compositions containing prostacyclin synthase gene |
| 05/10/2011 | CA2406664C Systemic delivery of neural stem cells to treat cancer |
| 05/10/2011 | CA2394856C Enzyme treatment for infection |
| 05/10/2011 | CA2387576C Immuno-interactive fragments of the .alpha.c subunit of inhibin |
| 05/10/2011 | CA2379346C Conjugate for mediating cell-specific, compartment-specific or membrane-specific transport of active substances |
| 05/10/2011 | CA2375605C Peptide leukotriene receptor |
| 05/10/2011 | CA2363712C Long lasting insulinotropic peptides |
| 05/10/2011 | CA2344590C Treatment of inflammatory disease |
| 05/10/2011 | CA2314996C Carbohydrate oxidase and use thereof in baking |
| 05/10/2011 | CA2306441C Peptides derived from the env gene of the feline immunodeficiency virus and their applications |
| 05/10/2011 | CA2304810C Tie receptor tyrosine kinase ligand homologues |
| 05/10/2011 | CA2292898C Bacterial pheromones and uses therefor |
| 05/10/2011 | CA2248016C Direct molecular diagnosis of friedreich ataxia |
| 05/10/2011 | CA2171589C Phosphonomonoester nucleic acids, process for their preparation, and their use |
| 05/10/2011 | CA2165458C Intracellular binding proteins and use thereof |
| 05/09/2011 | CA2720567A1 Transgenic non-human animal and methods for stem cell engraftment |
| 05/05/2011 | WO2011054001A2 Analogs of pitutary adenylate cyclase-activating polypeptide (pacap) and methods for their use |
| 05/05/2011 | WO2011053991A2 Vault complexes for cytokine delivery |
| 05/05/2011 | WO2011053982A2 Therapeutic nuclease compositions and methods |
| 05/05/2011 | WO2011053825A2 Compositions and methods for the treatment or prevention of mitochondrial diseases |
| 05/05/2011 | WO2011053822A2 Notch inhibition in the treatment and prevention of obesity and metabolic syndrome |
| 05/05/2011 | WO2011053821A1 Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same |
| 05/05/2011 | WO2011053789A2 Pharmaceutical composition and methods to enhance cytotoxic t-cell recognition and maintain t-cell memory against a pathogenic disease |
| 05/05/2011 | WO2011053768A2 System and method for stabilizing corneal tissue after treatment |
| 05/05/2011 | WO2011053750A2 Drug resistant immunotherapy for treatment of a cancer |
| 05/05/2011 | WO2011053738A1 Method of producing recombinant vitamin k dependent proteins |
| 05/05/2011 | WO2011053675A2 Improved neurturin molecules |
| 05/05/2011 | WO2011053617A1 Dosage regimens for hcv combination therapy comprising bi201335, interferon alpha and ribavirin |
| 05/05/2011 | WO2011053191A1 Agent for treating stress-related diseases and disorders in humans and animals, and treatment and/or prevention method using said agent |
| 05/05/2011 | WO2011052883A2 Method for activating a natural killer cell by adjusting the expression of the socs2 gene |
| 05/05/2011 | WO2011052697A1 Protein having cedar pollen immunogenicity, polynucleotide for coding for said protein, and uses of said protein and polynucleotide |
| 05/05/2011 | WO2011052668A1 Tissue-regeneration promoter using recruitment of bone marrow mesenchymal stem cells and/or pluripotent stem cells in blood |
| 05/05/2011 | WO2011052523A1 Glycosylated form of antigenic glp-1 analogue |
| 05/05/2011 | WO2011052089A1 Carrier materials for in vivo sustained release of drug comprising ionizing radiation-crosslinked hydrogel and method for producing same |
| 05/05/2011 | WO2011051692A1 Therapeutic peptides |
| 05/05/2011 | WO2011051486A2 Pharmaceutical solution of non covalently bound albumin and acylated insulin |
| 05/05/2011 | WO2011051482A1 Nutritional compositions comprising lactoferrin and probiotics and kits of parts thereof |
| 05/05/2011 | WO2011051457A2 Purified emd protein composition |
| 05/05/2011 | WO2011051392A1 Phosphorylated twist1 and cancer |
| 05/05/2011 | WO2011051346A1 Composition to induce specific immune tolerance |
| 05/05/2011 | WO2011051073A1 New bacitracin antibiotics |
| 05/05/2011 | WO2011050948A1 Tape, in particular adhesive tape, for the treatment of skin disorders comprising a film, in particular dissolvable film, containing at least one enzyme |
| 05/05/2011 | WO2011050808A1 Use of carbamylated erythropoietin for the treatment of friedreich's ataxia |
| 05/05/2011 | WO2011050709A1 Use of interleukin-1 receptor antagonist for preparing medicament for preventing or treating epithelium trauma of intestinal mucosa |
| 05/05/2011 | WO2011050599A1 Humanized recombinant uricase and mutants thereof |
| 05/05/2011 | WO2011050471A1 Yellow pea seed protein-derived peptides |
| 05/05/2011 | WO2011050379A1 Use of gstp1 |
| 05/05/2011 | WO2011031713A8 Method for the treatment of pulmonary disease and method of producing proteins of use therein |
| 05/05/2011 | WO2011029980A8 Therapeutic compositions for the treatment of hpv-induced diseases |
| 05/05/2011 | WO2011005939A3 Long acting atrial natriuretic peptide (la-anp) and methods for use thereof |
| 05/05/2011 | WO2010148007A3 Nanoparticle and polymer formulations for thyroid hormone, analogs, antagonists, and formulations and uses thereof |
| 05/05/2011 | WO2010118384A8 Amylin agonist compounds for estrogen-deficient mammals |
| 05/05/2011 | WO2010111597A3 Immunodominant compositions and methods of use therefor |
| 05/05/2011 | WO2010040000A8 A multicomponent vaccine for malaria providing long-lasting immune responses against plasmodia |
| 05/05/2011 | US20110107444 Novel poly(adp-ribose) polymerase genes |
| 05/05/2011 | US20110107443 Novel protein transduction domains derived from secretory leukocyte protease inhibitor |
| 05/05/2011 | US20110105996 Methods for scar prevention |
| 05/05/2011 | US20110105959 Novel Methods for Bone Treatment by Modulating an Arachidonic Acid Metabolic or Signaling Pathway |
| 05/05/2011 | US20110105731 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 05/05/2011 | US20110105721 Peptides |
| 05/05/2011 | US20110105718 Nel-related protein type 1 antibody |
| 05/05/2011 | US20110105417 Drug Conjugates |
| 05/05/2011 | US20110105416 Novel Antimicrobial Peptides |
| 05/05/2011 | US20110105415 Gene regulator |
| 05/05/2011 | US20110105414 Cyclic, cystein-free protein |
| 05/05/2011 | US20110105413 Polymeric systems containing intracellular releasable disulfide linker for the delivery of oligonucleotides |
| 05/05/2011 | US20110105412 Conjugated molecules comprising a peptide derived from the cd4 receptor coupled to a polyanion for the treatment of aids |
| 05/05/2011 | US20110105411 Disease-Associated Proteins |
| 05/05/2011 | US20110105410 Beta-Turn Peptidomimetic Cyclic Compounds for Treating Dry Eye |
| 05/05/2011 | US20110105409 Anticancer Compounds |
| 05/05/2011 | US20110105408 Therapeutic peptides |
| 05/05/2011 | US20110105407 Tissue Inhibitor of Metalloproteinases (Timp) Linked to Glycosylphosphatidylinositol (Gpi) - Anchors for Treatment of Cancer and Skin Lesions |
| 05/05/2011 | US20110105405 Method for alleviating pain using protein associated with myc and related compounds, and assays for identifying such compounds |
| 05/05/2011 | US20110105404 Beta Sheet Inhibiting Peptides For Preventing And/Or Treating Alzheimer`s Disease |
| 05/05/2011 | US20110105403 Peptides |
| 05/05/2011 | US20110105402 Silk Peptide For Improving Neuroprotective And Neurofunctional Effects And A Method Of Its Prepartion |
| 05/05/2011 | US20110105401 Peptide composition and a method of promoting cartilage formation |
| 05/05/2011 | US20110105400 Methods for treating acute myocardial infarction |
| 05/05/2011 | US20110105399 Prevention and treatment of inflammation and organ injury after ischemia/reperfusion using mfg-e8 |
| 05/05/2011 | US20110105398 Recombinant fsh including alpha 2,3- and alpha 2,6-sailylatio |
| 05/05/2011 | US20110105397 Method for treating heart failure with stresscopin-like peptides |
| 05/05/2011 | US20110105396 Tgf-beta3 mutants |
| 05/05/2011 | US20110105395 Methods for treating a neurological disorder by peripheral administration of a trophic factor |
| 05/05/2011 | US20110105394 Amylin Derivatives |
| 05/05/2011 | US20110105393 Methods for promoting stem cell proliferation and survival |
| 05/05/2011 | US20110105392 Pegylated Insulin Lispro Compounds |
| 05/05/2011 | US20110105391 Methods and Compositions for Delivering Peptides |
| 05/05/2011 | US20110105390 Selection and treatment of patients suffering from wasting |
| 05/05/2011 | US20110105389 Macrocyclic Ghrelin Receptor Antagonists and Inverse Agonists and Methods of Using the Same |
| 05/05/2011 | US20110105388 Novel possibility of controlling giardiosis |
| 05/05/2011 | US20110105387 Method of treatment with rapamycin |
| 05/05/2011 | US20110105386 Use of antimicrobial polymers for re-sensitization of microorganisms upon emergence of resistance to anti-microbial agents |
| 05/05/2011 | US20110105385 Antibacterial lactobacillus GG peptides and methods of use |
| 05/05/2011 | US20110105383 Methods and compositions for stimulation of mammalian innate immune resistance to pathogens |
| 05/05/2011 | US20110105382 Calmodulin-binding peptides that reduce cell proliferation in cancer and smooth muscle proliferation diseases |
| 05/05/2011 | US20110105381 Prodrugs of Peripheral Phenolic Opioid Antagonists |
| 05/05/2011 | US20110105380 Protection of Nano-Scale Particles from Immune Cell Uptake |
| 05/05/2011 | US20110105379 Saccharide-containing protein conjugates and uses thereof |
| 05/05/2011 | US20110104756 HUMAN IgM ANTIBODIES, AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF PARTICULARLY IN THE CENTRAL NERVOUS SYSTEM |
| 05/05/2011 | US20110104715 Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof |